Where Will Gilead Sciences Be in 1 Year?
|
The
treatment led gains in Gilead's HIV portfolio, which posted a 14% ... is
organized into two geographic regions: Europe, and Africa, Middle East
and ...
|
View article...
View article...
Another step towards a cure: Vitamin A transporter reactivates latent HIV
Human immunodeficiency viruses ( HIV ) are insidious. They can evade the immune defence and antiviral drugs by becoming "latent". View article...